{"version":"1.0","type":"rich","title":"Phase 2 Established Dose from prior study, NCT03810196 for hemoglobinopathies","provider_name":"What came of it?","provider_url":"https://staging.whatcameofit.com/","html":"<iframe src=\"https://staging.whatcameofit.com/embed/phase-2-established-dose-from-prior-study-nct03810196--hemoglobinopathies\" title=\"Phase 2 Established Dose from prior study, NCT03810196 for hemoglobinopathies\" width=\"440\" height=\"420\" style=\"border:0;max-width:100%\" loading=\"lazy\"></iframe>","width":440,"height":420,"thumbnail_url":"https://staging.whatcameofit.com/brand-card.png?v=b7e2e5c93907","thumbnail_width":1200,"thumbnail_height":630,"cache_age":86400}